A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
A multicenter open label study to assess the efficacy of sildenafil rapid dose titration to
100 mg in men with erectile dysfunction, based on the Erectile Function (EF) domain score of
the International Index of Erectile Function (IIEF) questionnaire.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.